K.J. Harrison & Partners Inc Beam Therapeutics Inc. Transaction History

K.J. Harrison & Partners Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$36.73 - $51.6 $73,460 - $103,200	2,000 Added 30.78%	8,497 $0
Q3 2022 Oct 21, 2022	SELL	$39.79 - $70.31 $397,900 - $703,100	-10,000 Reduced 60.62%	6,497 $310,000
Q1 2022 Apr 21, 2022	BUY	$53.73 - $82.16 $268,650 - $410,800	5,000 Added 43.49%	16,497 $945,000
Q4 2021 Jan 26, 2022	BUY	$68.02 - $99.06 $476 - $693	7 Added 0.06%	11,497 $918,000
Q3 2021 Nov 05, 2021	SELL	$84.37 - $133.6 $253,110 - $400,800	-3,000 Reduced 20.7%	11,490 $1.01 Million
Q2 2021 Aug 04, 2021	BUY	$64.12 - $128.71 $387,284 - $777,408	6,040 Added 71.48%	14,490 $1.87 Million
Q1 2021 May 14, 2021	BUY	$71.28 - $120.75 $602,316 - $1.02 Million	8,450 New	8,450 $676,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.